Home Healthcare Pharmaceuticals Pericarditis Drugs Market

Pericarditis Drugs Market Size, Share & Trends Analysis Report By Product (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):, Colchicine, Corticosteroids, Others), By Route of Administration (Oral, Parenteral), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 18, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Pericarditis Drugs Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Non-Steroidal Anti-Inflammatory Drugs 
    2. Colchicine
    3. IL-1 inhibitors
    4. Corticosteroids
    5. Immunosuppressants
  2. Pericarditis Drugs Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Parenteral
  3. Pericarditis Drugs Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  4. Regional Pericarditis Drugs Market
    1. North America
      1. North America Pericarditis Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
      2. North America Pericarditis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. North America Pericarditis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.S.
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Canada
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    2. Europe
      1. Europe Pericarditis Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
      2. Europe Pericarditis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. Europe Pericarditis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.K.
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Germany
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. France
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. Spain
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Italy
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Russia
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Nordic
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      11. Benelux
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      12. Rest of Europe
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    3. APAC
      1. APAC Pericarditis Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
      2. APAC Pericarditis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. APAC Pericarditis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. China
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Korea
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Japan
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. India
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Australia
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Singapore
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Taiwan
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      11. South East Asia
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      12. Rest of Asia-Pacific
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Pericarditis Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
      2. Middle East and Africa Pericarditis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. Middle East and Africa Pericarditis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. UAE
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Turkey
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Saudi Arabia
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. South Africa
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Egypt
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Nigeria
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Rest of MEA
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    5. LATAM
      1. LATAM Pericarditis Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
      2. LATAM Pericarditis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. LATAM Pericarditis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. Brazil
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Mexico
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Argentina
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. Chile
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Colombia
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Rest of LATAM
        1. Non-Steroidal Anti-Inflammatory Drugs 
        2. Colchicine
        3. IL-1 inhibitors
        4. Corticosteroids
        5. Immunosuppressants
        6. Oral
        7. Parenteral
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.